Clinical diagnosis and treatment of eosinophilic asthma by respiratory physicians in China: a cross-sectional survey.

Xolair (omalizumab) - Roche, Novartis

Nucala (mepolizumab) - GSK

Fasenra (benralizumab) - AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/42724382

Jiaxing Xie; Lin Yu; Mei Jiang; Xuetao Kong; Yan Chen; Yongling Deng

Sep 12, 2026